MX2017013352A - Combinacion de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevencion y/o tratamiento de lesiones de la piel. - Google Patents

Combinacion de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevencion y/o tratamiento de lesiones de la piel.

Info

Publication number
MX2017013352A
MX2017013352A MX2017013352A MX2017013352A MX2017013352A MX 2017013352 A MX2017013352 A MX 2017013352A MX 2017013352 A MX2017013352 A MX 2017013352A MX 2017013352 A MX2017013352 A MX 2017013352A MX 2017013352 A MX2017013352 A MX 2017013352A
Authority
MX
Mexico
Prior art keywords
prevention
treatment
combination
protease inhibitor
active principle
Prior art date
Application number
MX2017013352A
Other languages
English (en)
Inventor
Assandri Alessandro
Original Assignee
Eurodrug Laboratories B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurodrug Laboratories B V filed Critical Eurodrug Laboratories B V
Publication of MX2017013352A publication Critical patent/MX2017013352A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

La invención se refiere a una combinación que comprende al menos un inhibidor de proteasa, que puede ser de diferentes orígenes, tal como plantas, frutas, salvado de arroz, semillas de frijol, soya o papa y al menos un principio activo adicional, seleccionado de óxido de zinc, dexpantenol, pantenol, cloruro de benzalconio, cetrimida, clotrimazol, nistatina, dimeticona, aloe vera o caléndula y a su uso en la prevención y/o tratamiento de lesiones de la piel causadas por orina y/o heces y como adyuvante en la reparación de la piel. La invención además se refiere a dicha combinación en asociación con principios activos adicionales y a su uso en la prevención y/o tratamiento de lesiones de piel causadas por proteasas en las heces y como adyuvante en la reparación de la piel.
MX2017013352A 2015-04-17 2015-04-17 Combinacion de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevencion y/o tratamiento de lesiones de la piel. MX2017013352A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2015/058451 WO2016165783A1 (en) 2015-04-17 2015-04-17 Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions

Publications (1)

Publication Number Publication Date
MX2017013352A true MX2017013352A (es) 2018-06-22

Family

ID=52988064

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017013352A MX2017013352A (es) 2015-04-17 2015-04-17 Combinacion de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevencion y/o tratamiento de lesiones de la piel.

Country Status (18)

Country Link
EP (1) EP3283093B1 (es)
KR (1) KR102359285B1 (es)
CN (1) CN107683144B (es)
AR (1) AR104265A1 (es)
BR (1) BR112017022286A2 (es)
CO (1) CO2017010543A2 (es)
DK (1) DK3283093T3 (es)
ES (1) ES2830379T3 (es)
HK (1) HK1246205A1 (es)
HR (1) HRP20201777T1 (es)
HU (1) HUE052035T2 (es)
MX (1) MX2017013352A (es)
MY (1) MY196133A (es)
PH (1) PH12017501889A1 (es)
PT (1) PT3283093T (es)
RS (1) RS61576B1 (es)
SG (1) SG11201708214UA (es)
WO (1) WO2016165783A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112402273B (zh) * 2020-12-01 2023-10-03 金发拉比妇婴童用品股份有限公司 一种改善婴幼儿红屁股的膏霜及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3079599A (en) * 1998-03-12 1999-09-27 Procter & Gamble Company, The Disposable absorbent article having a skin care composition containing an enzymeinhibitor
EP0958833A1 (en) * 1998-05-20 1999-11-24 Erasmus Universiteit Rotterdam Methods and means for preventing or treating inflammation
US6207596B1 (en) * 1998-11-09 2001-03-27 The Procter & Gamble Company Disposable premoistened wipe containing an antimicrobial protease inhibitor
US7005557B2 (en) * 2001-07-03 2006-02-28 The Procter & Gamble Company Film-forming compositions for protecting skin from body fluids and articles made therefrom
US20050175719A1 (en) * 2004-02-05 2005-08-11 Ying Sun Procyanidins for treatment and prevention of enzymatic irritation to the skin
EP1586336A1 (en) * 2004-04-06 2005-10-19 JOHNSON & JOHNSON GmbH Compositions containing copper salts and soy products
NZ547991A (en) * 2005-06-22 2008-08-29 Bristol Myers Squibb Co Enzyme inhibiting sprayable skin barrier compositions comprising enzyme inhibitors derived from potatoes

Also Published As

Publication number Publication date
PT3283093T (pt) 2020-11-03
PH12017501889A1 (en) 2018-03-05
EP3283093B1 (en) 2020-09-16
AR104265A1 (es) 2017-07-05
CN107683144A (zh) 2018-02-09
CN107683144B (zh) 2020-08-07
BR112017022286A2 (pt) 2018-07-10
DK3283093T3 (da) 2020-11-09
KR102359285B1 (ko) 2022-02-07
ES2830379T3 (es) 2021-06-03
HUE052035T2 (hu) 2021-04-28
RS61576B1 (sr) 2021-04-29
HK1246205A1 (zh) 2018-09-07
MY196133A (en) 2023-03-16
HRP20201777T1 (hr) 2021-01-08
KR20180003553A (ko) 2018-01-09
SG11201708214UA (en) 2017-11-29
CO2017010543A2 (es) 2018-03-09
WO2016165783A1 (en) 2016-10-20
EP3283093A1 (en) 2018-02-21

Similar Documents

Publication Publication Date Title
PH12015501983A1 (en) Peptides and compositions for treatment of joint damage
LT2968434T (lt) C1-inh kompozicijos, skirtos panaudoti paveldimos angiodemos prevencijai ir gydymui
IL215592A (en) Compounds, preparations containing them and their uses in the treatment or prevention of conditions in the eyes
CU20150091A7 (es) Estra-1, 3,5(10), 16tetraeno-3-carboxamidas para la inhibición de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
MX2017015700A (es) Igfbp3 y sus usos.
WO2012158672A3 (en) Compounds for use in treatment of mucositis
WO2015026494A3 (en) Methods for treating tissue fibrosis
TW201613634A (en) Use of elsiglutide to treat gastrointestinal mucositis including chemotherapy-induced diarrhea
GB2543723A (en) Polyphenol compositions
PH12017501889A1 (en) Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions
MX2018002836A (es) Métodos para reducir contaminantes en productos agrícolas con ozono húmedo.
MX2017003360A (es) Composicion para la prevencion y/o tratamiento de sintomas de alergia.
BRPI1002094A2 (pt) Utilização de pelo menos uma forma peptidica solúvel, e processos de triagem de ativos anti-idade e de caracterização da eficácia de um tratamento
WO2015044317A3 (en) Staphylococcus haemolyticus inhibitors for preventing and/or treating atopic dermatitis
MX2016015114A (es) Producto de avena enriquecido con avenatramidas.
DOP2017000238A (es) Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel
CL2017002630A1 (es) Combinación de al menos un inhibidor de proteasa y al menos un principio activo para su uso en la prevención y/o tratamiento de lesiones de piel
WO2011067608A8 (en) Treatment of allodynia and hyperalgesia
PH12016501448B1 (en) Antifungal composition
EP4293036A3 (en) Structure of gii.4 norovirus protease -design of broad-spectrum protease inhibitors
WO2016046759A3 (en) Compositions and methods for treating friedreich's ataxia
PH12019500464A1 (en) An oxazine derivative for use in the treatment or prevention of cerebral amyloid angiopathy
GEP20197038B (en) Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions
TH1701006167A (th) สารรวมของอย่างน้อยที่สุดหนึ่งตัวยับยั้งโปรตีเอส และอย่างน้อยที่สุดหนึ่งสารออกฤทธิ์สำหรับการใช้ในการป้องกัน และ/หรือ การรักษารอยโรคที่ผิวหนัง
WO2015013285A3 (en) Methods for reducing the occurrence of hot flashes